May 5, 2011

Tempo Scan takeover & the buyer

In the last 1 month, one of Indonesia's largest drug maker PT Tempo Scan Pacific Tbk, with sales half of its contender PT Kalbe Farma Tbk (KLBF), surged 21.43% and ended at Rp2,125 per share at closing today.
A market speculation said one consortium of Indonesian' richest conglomerates has agreed to acquire the entire shareholding in Tempo Scan from Kartini Muljadi's family at the consideration price of Rp2,200-Rp2,300 per share, reflecting 20.10x-20.18x price to earning ratio (PER) of 2010.
The acquisition price is nearly 30% cheaper than 28.16x PER of Kalbe Farma last year. Who is the buyer? Is it Kalbe Farma? Read the remaining story or please login or register.    

Disclosure: No position at the stock mentioned above.
Print This Article

No comments: